Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
34.08
+0.06 (0.18%)
Dec 20, 2024, 4:00 PM EST - Market closed
Legend Biotech Employees
Legend Biotech had 1,826 employees as of December 31, 2023. The number of employees increased by 436 or 31.37% compared to the previous year.
Employees
1,826
Change (1Y)
436
Growth (1Y)
31.37%
Revenue / Employee
$284,876
Profits / Employee
-$190,651
Market Cap
6.25B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,826 | 436 | 31.37% |
Dec 31, 2022 | 1,390 | 319 | 29.79% |
Dec 31, 2021 | 1,071 | 189 | 21.43% |
Dec 31, 2020 | 882 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Grifols | 23,737 |
Bausch + Lomb | 13,300 |
Elanco Animal Health | 9,800 |
Jazz Pharmaceuticals | 2,800 |
Waystar Holding | 1,400 |
Lantheus Holdings | 834 |
Revolution Medicines | 378 |
Madrigal Pharmaceuticals | 376 |
LEGN News
- 2 days ago - Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 12 days ago - CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma - GlobeNewsWire
- 16 days ago - Legend Biotech: The Story Brightens - Seeking Alpha
- 5 weeks ago - Legend Biotech Corporation (LEGN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition - GlobeNewsWire
- 6 weeks ago - Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma - GlobeNewsWire
- 6 weeks ago - Legend Biotech Appoints Alan Bash as President of CARVYKTI® - GlobeNewsWire
- 2 months ago - Stock Picks From Seeking Alpha's September 2024 New Analysts - Seeking Alpha